As of April 16, 2025, BB Biotech (BION.SW) has a market cap of $1.80 billion USD. According to our data, BB Biotech is ranked No.4135 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $1.80 B |
-23.82%
|
Dec 30, 2024 | $2.37 B |
-13.52%
|
Dec 29, 2023 | $2.74 B |
-18.05%
|
Dec 30, 2022 | $3.34 B |
-24.29%
|
Dec 30, 2021 | $4.41 B |
8.36%
|
Dec 30, 2020 | $4.07 B |
19.31%
|
Dec 30, 2019 | $3.41 B |
23.93%
|
Dec 28, 2018 | $2.76 B |
-5.11%
|
Dec 29, 2017 | $2.90 B |
23.14%
|
Dec 30, 2016 | $2.36 B |
0.33%
|
Dec 30, 2015 | $2.35 B |
28.18%
|
Dec 30, 2014 | $1.83 B |
75.15%
|
Dec 30, 2013 | $1.05 B |
65.96%
|
Dec 28, 2012 | $0.63 B |
42.74%
|
Dec 30, 2011 | $0.44 B |
5.56%
|
Dec 30, 2010 | $0.42 B |
-15.06%
|
Dec 31, 2009 | $0.49 B |
14.89%
|
Dec 31, 2008 | $0.43 B |
-18.72%
|
Dec 31, 2007 | $0.53 B |
-6.84%
|
Dec 29, 2006 | $0.57 B |
19.12%
|
Dec 30, 2005 | $0.48 B |
19.46%
|
Dec 31, 2004 | $0.40 B |
14.63%
|
Dec 31, 2003 | $0.35 B |
10.83%
|
Dec 31, 2002 | $0.31 B |
-54.83%
|
Dec 31, 2001 | $0.69 B |
-28.55%
|
Dec 29, 2000 | $0.97 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.12 B |
0.000 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Moderna
MRNA
|
$10.14 B |
-0.001 M
|
![]() USA
|
![]() BioNTech
BNTX
|
$23.80 B |
0.001 M
|
![]() Germany
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
Market Cap | = | BION.SW Stock Price | * | BION.SW Shares Outstanding |
= | $32.95 | * | 54.76 M | |
= | $1.80 B |